Advanced airway management integrates basic airway instrumentations, tracheal intubation, and emergency front of neck access to maintain oxygenation and ventilation in perioperative and critical care settings. The ability to ventilate a patient using bag-valve mask technique is an essential tool for every health care provider. When this basic technique is ineffective, direct laryngoscopy facilitates visualization of airway anatomy and placement of intubation devices. This includes the use of supraglottic airway and endotracheal tubes. When nonsurgical techniques fail, cricothyrotomy provides rapid, life-saving access to the trachea.
Modern dental sedation is transitioning from traditional long-acting agents toward fast-acting pharmacology characterized by organ-independent metabolism and rapid offset. In this article, we review the pharmacodynamics of inhalational agents (nitrous oxide, sevoflurane) and comprehensively evaluate novel intravenous agents: remimazolam, remifentanil, and fospropofol. Many practitioners are looking beyond traditional propofol, prompted by its narrow safety margins and the intensive airway training required to use it responsibly in a dental setting. We analyze mechanism-specific advantages, dosing protocols, and complication management. Furthermore, we detail advanced clinical strategies, including sequential benzodiazepine sedation and multi-modal total intravenous anesthesia (TIVA), equipping the oral and maxillofacial surgeon with evidence-based protocols to optimize hemodynamic stability and recovery efficiency in the outpatient setting.
The article provides evidence-based treatment guidance, including specific medications, dosages, routes, airway management, and positioning techniques tailored to office-based settings. It emphasizes early recognition, appropriate monitoring, and timely intervention, including escalation of care. It also highlights the need for preparedness, proper equipment, and regular training so dental professionals can effectively manage complications and ensure patient safety.
Outpatient sedation in oral and maxillofacial surgery integrates pharmacologic agents, physiologic monitoring, and airway management principles to safely perform procedures in healthy adult patients. Intravenous sedation remains the primary modality due to its rapid onset, titratability, and predictable recovery. Commonly used agents include benzodiazepines, opioids, propofol, ketamine, and dexmedetomidine, often in multimodal combinations. Safe practice requires understanding sedation depth, drug interactions, and airway physiology, as well as the ability to recognize and manage complications such as laryngospasm and bronchospasm. Thoughtful use of adjunctive medications further enhances patient comfort and postoperative outcomes.
This article provides a review of conscious sedation in dental practice, emphasizing safe techniques for managing patient anxiety across oral, intranasal, and intramuscular routes. Emphasis is placed on preoperative assessment, including airway evaluation and behavior scoring in pediatrics. Pharmacologic profiles of sedative agents are reviewed. Postoperative recovery and discharge protocols are discussed with a focus on patient safety and evidence-based practice.
Intravenous sedation is a key component of oral and maxillofacial surgery, improving patient comfort and procedural tolerance. Safe administration depends on a structured pre-sedation evaluation that includes comprehensive medical history, airway assessment, ASA classification, BMI evaluation, and screening for obstructive sleep apnea. Systemic conditions such as diabetes, anemia, sickle cell disease, and adrenal insufficiency significantly influence sedation risk and require individualized management. Together, these criteria support effective risk stratification, guide sedation planning, and align with professional standards to optimize patient safety and outcomes.
This article outlines essential guidelines and protocols for safe outpatient sedation practice. It emphasizes the clinician's responsibility to prevent and detect life-threatening complications by adhering to recommended monitoring standards. All patients, regardless of sedation depth, must be monitored for oxygenation, ventilation, and hemodynamics. Core requirements include the use of non-invasive devices such as a blood pressure cuff, pulse oximeter, and stethoscope, with capnography mandated for moderate to deep sedation. The article also highlights advanced wireless monitoring tools for early detection of airway complications. Additionally, it underscores the critical importance of comprehensive documentation.
This article reviews the role of outpatient dental sedation in managing patients with dental anxiety or phobia. Sedation helps reduce pain, fear, and memory of procedures while improving patient cooperation and treatment outcomes. The article discusses commonly used sedative and adjunct medications, including midazolam, remimazolam, propofol, ketamine, opioids such as fentanyl and remifentanil, and supportive drugs like dexmedetomidine, diphenhydramine, atropine, glycopyrrolate, and ondansetron. Newer agents such as remimazolam and ketofol combinations may offer improved safety and recovery profiles. Overall, the article emphasizes individualized patient care and thorough pharmacologic knowledge to ensure safe and effective outpatient dental sedation.
